

Please try another search
By Sam Boughedda
Investing.com -- Shares of AbbVie Inc (NYSE:ABBV) fell 5% in Wednesday's session after the announcement that Vice Chairman and President Michael Severino would be leaving the company.
In a regulatory filing, AbbVie said Severino will be joining a "bioplatform innovation company as CEO-Partner and as CEO of one of its companies," effective May 31.
However, Wells Fargo (NYSE:WFC) analyst Mohit Bansal said in a note to clients, quoted by TheFly, that he believes the weakness in AbbVie's shares is a buying opportunity.
The analyst, who has an overweight rating and $165 price target on the stock, thinks the weakness was because some investors viewed Severino as a potential successor to Chief Executive Richard Gonzalez.
Bansal added that AbbVie told him that Severino's departure would not affect its succession planning process and that it is still on track for 2023.
Severino departing will not be "hugely disruptive to either succession planning or R&D strategy," wrote the analyst.
Despite Wednesday's fall, AbbVie stock is still up 17.35% in 2022.
By Senad Karaahmetovic FTX, one of the world’s largest digital asset exchanges, was considering a deal to buy the embattled crypto lender Celsius, The Block reports. FTX, led by a...
(Reuters) - Strikes and staff shortages are forcing airlines to cancel thousands of flights and causing hours-long queues at major airports, dashing hopes of a sizzling first...
It was announced yesterday that Palantir Technologies (NYSE:PLTR) is one of two companies awarded a contract by the U.S. Army for the Tactical Intelligence Targeting Access Node...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.